Next Century Growth Investors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Next Century Growth Investors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,112,751	Closed	-$18M	–	161
2016 Q4	$18M	Sell	1,112,751 -251,094	-18%	-$4.55M	1.1%	31
2016 Q3	$24.7M	Buy	+1,363,845	New	+$26.6M	1.13%	24
2016 Q1	–	Sell	-519,383	Closed	-$11.3M	–	187
2015 Q4	$11.3M	Buy	519,383 +234,094	+82%	+$4.56M	0.49%	59
2015 Q3	$5.65M	Buy	285,289 +12,862	+5%	+$406K	0.23%	113
2015 Q2	$9.46M	Buy	+272,427	New	+$8.31M	0.33%	90

Other funds holding HZNP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Next Century Growth Investors's HZNP Position: Q1 2017 in Review

Next Century Growth Investors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2017, closing a stake of 1,112,751 shares — an estimated $18M sold.

Next Century Growth Investors first reported a position in HZNP in Q2 2015 and held it in 5 quarters. The position peaked at $24.7M in Q3 2016. 210 funds tracked by Wall St. Rank hold HZNP as of Q1 2017.

Next Century Growth Investors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2017 after selling out during the quarter.
Next Century Growth Investors sold 1,112,751 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2017, an estimated $18M.
Next Century Growth Investors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 5 quarters.
Next Century Growth Investors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $24.7M in Q3 2016.
210 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2017.

Based on Next Century Growth Investors's 13F filing for Q1 2017, filed 12 May 2017.